Docon Technologies Sells 5.3 Million Shares in Thyrocare

Promoter Sale: Docon Technologies sold 5.33 million shares, reducing its stake by over 10%.
Institutional Interest: Asset managers picked up 7.9% stake, worth ₹527 crore.
Deal Value: Total transaction size was ₹667.7 crore at ₹1,252.03 per share.
Market Reaction: Thyrocare stock rose 1.13%, signaling positive sentiment.
Ownership Shift: Promoter holding now stands near 61%, enhancing public float.

Image Source: SaasCounter

Promoter Docon Technologies has sold 5.33 million shares of Thyrocare Technologies Ltd, representing 10.06% of the company’s paid-up equity, via a bulk deal on October 24, 2025. The transaction, valued at ₹667.7 crore, saw institutional investors acquire a 7.9% stake, signaling strong market interest.